Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.35 |
| ▸ | PPARG | P37231 | 4/20 | 0.33 |
| ▸ | PPARA | Q07869 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.32 |
| ▸ | RARA | P10276 | 1/20 | 0.31 |
| ▸ | RARB | P10826 | 1/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.31 |
| ▸ | CDC7 | O00311 | 1/20 | 0.31 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.31 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4029418 | 0.78 | FFAR1 (0.40) | HRH3PPARGPPARAMEN1KMT2A | |
| SCHEMBL4038650 | 0.77 | GABRA5 (0.36) | HRH3PPARGPPARAKDM4EMEN1 | |
| SCHEMBL4035249 | 0.65 | CCNB2 (0.47) | MEN1ALDH1A1KMT2A | |
| SCHEMBL4038452 | 0.64 | ALDH1A1 (0.49) | HRH3PPARGPPARAKDM4EMEN1 | |
| SCHEMBL4035340 | 0.63 | KDM4E (0.41) | HRH3PPARGPPARAKDM4EALDH1A1 | |
| SCHEMBL4034230 | 0.62 | FFAR1 (0.58) | PPARGPPARA | |
| SCHEMBL4032477 | 0.62 | FFAR1 (0.45) | PPARGPPARAROCK2 | |
| SCHEMBL4031214 | 0.62 | MEN1 (0.43) | HRH3PPARGPPARAKDM4EMEN1 | |
| SCHEMBL4035756 | 0.61 | PPARA (0.37) | PPARGPPARAKDM4EMEN1ALDH1A1 | |
| SCHEMBL4034640 | 0.61 | HRH3 (0.43) | HRH3PPARGPPARAKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058965-A1 | Alkanoic acid derivatives process for their production and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058965-A1 | Alkanoic acid derivatives process for their production and use thereof | GPR119, ACOX1, ALK | HRH3 442/4885PPARG 593/4885PPARA 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.